Oasmia Pharma Balance Sheet - Annual (NASDAQ:OASM)

Add to My Stocks
$2.56 $0.19 (6.91%) OASM stock closing price Sep 20, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Oasmia Pharma, and helps in stock analysis. As in our Oasmia Pharma stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. Good annual results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Oasmia Pharma had a long term debt of $- at the end of 2018. To understand the debt servicing capacity of the company, one needs to look at Oasmia Pharma operating cash flow and Oasmia Pharma revenue also. Oasmia Pharma debt to equity ratio is 0.51.

View latest 10 year balance sheet data to check Oasmia Pharma financial performance.
show more
Fiscal year is May - Apr20182017201620152014
Cash1.87M3.2M3.19M3.61M7.39M
Marketable Securities--2.43M6.75M-
Receivables4.33M----
Inventory1.17M1.56M2.02M--
Raw Materials-----
Work In Progress-----
Finished Goods-----
Notes Receivable-----
Other Current Assets2.31M----
Total Current Assets
9.7M5.73M8.83M11.66M8.32M
Property Plant & Equipment-6M6.33M6.75M7.43M
Accumulated Depreciation-3.9M3.75M3.67M3.69M
Net Property Plant & Equipment
1.87M2.1M2.57M3.07M3.74M
Investment & Advances-----
Other Non-Current Assets-----
Deferred Charges-----
Intangibles5.54M4.13M1.45M1.59M2.04M
Deposits & Other Assets51.38M47.69M49.92M52.92M57.69M
Total Assets
68.5M59.66M62.79M69.26M71.8M
Notes Payable-----
Accounts Payable1.11M2.38M3.31M1.88M2.68M
Current Portion Long-Term Debt22.58M11.71M14.6M11.71M16.09M
Current Portion Capital Leases-----
Accrued Expenses2.77M3M2.46M2.15M3.29M
Income Taxes Payable-----
Other Current Liabilities-8.19M2.68M2.93M6.37M
Total Current Liabilities
26.89M25.3M23.08M18.69M28.45M
Mortgages-----
Deferred Taxes/Income-----
Convertible Debt-----
Long-Term Debt-----
Non-Current Capital Leases-----
Other Long-Term Liabilities-----
Total Liabilities
26.89M25.3M23.08M18.69M28.58M
Minority Interest-----
Preferred Stock-----
Common Stock Net2.12M1.36M1.3M1.31M1.31M
Capital Surplus-----
Retained Earnings-109.12M-90.01M-76.32M-65.29M-56.34M
Treasury Stock-----
Other Liabilities148.61M123.01M114.72M114.54M98.25M
Shareholders Equity41.61M34.36M39.71M50.57M43.21M
Total Liabilities & Shareholders Equity68.5M59.66M62.79M69.26M71.8M
All figures in USD. M: Millions of USD, B: Billions of USD.

The latest Oasmia Pharma stock price, and Oasmia Pharma historical stock prices show the stock price movement over time, and the Oasmia Pharma PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: OASM total assets, which was at $68.5M for 2018 is a balance sheet item representing value of what Oasmia Pharma owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Oasmia Pharma's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for OASM stock stand at $26.89M.

Oasmia Pharma Balance Sheet - Key Ratios

Current ratio
0.23
Debt to equity ratio
0.51
Asset turnover ratio
0
Receivables turnover
0.25
Price to book ratio
3.37

Annual Balance Sheets For Oasmia Pharmaceutical AB - American Depositary Shares Peers

CTI BioPharma balance sheet, MOLECULAR TEMPL balance sheet, PROCESSA PHARMA balance sheet, Vernalis balance sheet